nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—ADRB1—dilated cardiomyopathy	0.638	1	CbGaD
Bromocriptine—Gastric haemorrhage—Spironolactone—dilated cardiomyopathy	0.0246	0.178	CcSEcCtD
Bromocriptine—HTR2B—cardial valve—dilated cardiomyopathy	0.0187	0.332	CbGeAlD
Bromocriptine—ABCB1—Lisinopril—dilated cardiomyopathy	0.0116	0.532	CbGbCtD
Bromocriptine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0103	0.468	CbGbCtD
Bromocriptine—HTR7—pulmonary artery—dilated cardiomyopathy	0.00648	0.115	CbGeAlD
Bromocriptine—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.0063	0.112	CbGeAlD
Bromocriptine—Hypotensive—Furosemide—dilated cardiomyopathy	0.0046	0.0334	CcSEcCtD
Bromocriptine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.00404	0.0718	CbGeAlD
Bromocriptine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.00393	0.0699	CbGeAlD
Bromocriptine—Diabetic—Lisinopril—dilated cardiomyopathy	0.00377	0.0274	CcSEcCtD
Bromocriptine—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00316	0.0229	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00283	0.0206	CcSEcCtD
Bromocriptine—DRD4—heart—dilated cardiomyopathy	0.00281	0.05	CbGeAlD
Bromocriptine—Lung infiltration—Lisinopril—dilated cardiomyopathy	0.00268	0.0195	CcSEcCtD
Bromocriptine—Lethargy—Spironolactone—dilated cardiomyopathy	0.00228	0.0166	CcSEcCtD
Bromocriptine—Ataxia—Spironolactone—dilated cardiomyopathy	0.00211	0.0153	CcSEcCtD
Bromocriptine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00202	0.0146	CcSEcCtD
Bromocriptine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00173	0.0125	CcSEcCtD
Bromocriptine—Vasculitis—Furosemide—dilated cardiomyopathy	0.00172	0.0125	CcSEcCtD
Bromocriptine—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00164	0.0119	CcSEcCtD
Bromocriptine—ADRB1—cardiac ventricle—dilated cardiomyopathy	0.00164	0.0292	CbGeAlD
Bromocriptine—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00155	0.0113	CcSEcCtD
Bromocriptine—ADRB1—myocardium—dilated cardiomyopathy	0.00155	0.0275	CbGeAlD
Bromocriptine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00154	0.0112	CcSEcCtD
Bromocriptine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0015	0.0109	CcSEcCtD
Bromocriptine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.0014	0.0102	CcSEcCtD
Bromocriptine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00137	0.00993	CcSEcCtD
Bromocriptine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0013	0.0094	CcSEcCtD
Bromocriptine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00129	0.00936	CcSEcCtD
Bromocriptine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00126	0.00913	CcSEcCtD
Bromocriptine—Lethargy—Furosemide—dilated cardiomyopathy	0.00124	0.00902	CcSEcCtD
Bromocriptine—ADRA2C—cardiac ventricle—dilated cardiomyopathy	0.00124	0.022	CbGeAlD
Bromocriptine—ADRA2C—myocardium—dilated cardiomyopathy	0.00116	0.0207	CbGeAlD
Bromocriptine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00116	0.0084	CcSEcCtD
Bromocriptine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00113	0.00817	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00111	0.00807	CcSEcCtD
Bromocriptine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00111	0.00805	CcSEcCtD
Bromocriptine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.0011	0.00796	CcSEcCtD
Bromocriptine—ADRB1—heart—dilated cardiomyopathy	0.00108	0.0192	CbGeAlD
Bromocriptine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00105	0.00762	CcSEcCtD
Bromocriptine—HTR2B—heart—dilated cardiomyopathy	0.00103	0.0184	CbGeAlD
Bromocriptine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.001	0.00728	CcSEcCtD
Bromocriptine—Somnolence—Spironolactone—dilated cardiomyopathy	0.000978	0.0071	CcSEcCtD
Bromocriptine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000972	0.00706	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00095	0.00689	CcSEcCtD
Bromocriptine—Drowsiness—Furosemide—dilated cardiomyopathy	0.000939	0.00681	CcSEcCtD
Bromocriptine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000936	0.00679	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000933	0.00677	CcSEcCtD
Bromocriptine—ADRB1—cardiac atrium—dilated cardiomyopathy	0.000923	0.0164	CbGeAlD
Bromocriptine—Diplopia—Lisinopril—dilated cardiomyopathy	0.000914	0.00663	CcSEcCtD
Bromocriptine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000907	0.00658	CcSEcCtD
Bromocriptine—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.000907	0.00658	CcSEcCtD
Bromocriptine—HTR7—heart—dilated cardiomyopathy	0.000884	0.0157	CbGeAlD
Bromocriptine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000874	0.00634	CcSEcCtD
Bromocriptine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00087	0.00631	CcSEcCtD
Bromocriptine—Ataxia—Lisinopril—dilated cardiomyopathy	0.000859	0.00623	CcSEcCtD
Bromocriptine—ADRA1A—heart—dilated cardiomyopathy	0.000853	0.0152	CbGeAlD
Bromocriptine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000835	0.00606	CcSEcCtD
Bromocriptine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000823	0.00597	CcSEcCtD
Bromocriptine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000817	0.00593	CcSEcCtD
Bromocriptine—ADRA2C—heart—dilated cardiomyopathy	0.000813	0.0145	CbGeAlD
Bromocriptine—Visual impairment—Furosemide—dilated cardiomyopathy	0.000812	0.00589	CcSEcCtD
Bromocriptine—Influenza—Lisinopril—dilated cardiomyopathy	0.00079	0.00573	CcSEcCtD
Bromocriptine—Eye disorder—Furosemide—dilated cardiomyopathy	0.000787	0.00571	CcSEcCtD
Bromocriptine—Tinnitus—Furosemide—dilated cardiomyopathy	0.000786	0.0057	CcSEcCtD
Bromocriptine—Angiopathy—Furosemide—dilated cardiomyopathy	0.000764	0.00555	CcSEcCtD
Bromocriptine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000753	0.00546	CcSEcCtD
Bromocriptine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000753	0.00546	CcSEcCtD
Bromocriptine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000728	0.00528	CcSEcCtD
Bromocriptine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000718	0.00521	CcSEcCtD
Bromocriptine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000705	0.00512	CcSEcCtD
Bromocriptine—Vomiting—Spironolactone—dilated cardiomyopathy	0.0007	0.00508	CcSEcCtD
Bromocriptine—ADRA2C—cardiac atrium—dilated cardiomyopathy	0.000695	0.0124	CbGeAlD
Bromocriptine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000694	0.00504	CcSEcCtD
Bromocriptine—Rash—Spironolactone—dilated cardiomyopathy	0.000694	0.00503	CcSEcCtD
Bromocriptine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000693	0.00503	CcSEcCtD
Bromocriptine—Vision blurred—Furosemide—dilated cardiomyopathy	0.000691	0.00502	CcSEcCtD
Bromocriptine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00069	0.00501	CcSEcCtD
Bromocriptine—Headache—Spironolactone—dilated cardiomyopathy	0.000689	0.005	CcSEcCtD
Bromocriptine—Agitation—Furosemide—dilated cardiomyopathy	0.000674	0.00489	CcSEcCtD
Bromocriptine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000661	0.00479	CcSEcCtD
Bromocriptine—Vertigo—Furosemide—dilated cardiomyopathy	0.000659	0.00478	CcSEcCtD
Bromocriptine—Nausea—Spironolactone—dilated cardiomyopathy	0.000654	0.00474	CcSEcCtD
Bromocriptine—ADRA2A—heart—dilated cardiomyopathy	0.000649	0.0115	CbGeAlD
Bromocriptine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000644	0.00467	CcSEcCtD
Bromocriptine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000634	0.0046	CcSEcCtD
Bromocriptine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000629	0.00456	CcSEcCtD
Bromocriptine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000623	0.00452	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00062	0.0045	CcSEcCtD
Bromocriptine—Dry mouth—Furosemide—dilated cardiomyopathy	0.000611	0.00443	CcSEcCtD
Bromocriptine—Confusional state—Furosemide—dilated cardiomyopathy	0.000604	0.00438	CcSEcCtD
Bromocriptine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000589	0.00428	CcSEcCtD
Bromocriptine—Shock—Furosemide—dilated cardiomyopathy	0.000589	0.00427	CcSEcCtD
Bromocriptine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000587	0.00426	CcSEcCtD
Bromocriptine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000581	0.00422	CcSEcCtD
Bromocriptine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000574	0.00416	CcSEcCtD
Bromocriptine—Anorexia—Furosemide—dilated cardiomyopathy	0.000571	0.00414	CcSEcCtD
Bromocriptine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00057	0.00413	CcSEcCtD
Bromocriptine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000565	0.0041	CcSEcCtD
Bromocriptine—Hypotension—Furosemide—dilated cardiomyopathy	0.000559	0.00406	CcSEcCtD
Bromocriptine—Alopecia—Lisinopril—dilated cardiomyopathy	0.000559	0.00405	CcSEcCtD
Bromocriptine—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.000555	0.00986	CbGeAlD
Bromocriptine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000554	0.00402	CcSEcCtD
Bromocriptine—HTR2A—heart—dilated cardiomyopathy	0.000551	0.00981	CbGeAlD
Bromocriptine—Tension—Lisinopril—dilated cardiomyopathy	0.00054	0.00392	CcSEcCtD
Bromocriptine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000539	0.00391	CcSEcCtD
Bromocriptine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000538	0.0039	CcSEcCtD
Bromocriptine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000535	0.00388	CcSEcCtD
Bromocriptine—Somnolence—Furosemide—dilated cardiomyopathy	0.000532	0.00386	CcSEcCtD
Bromocriptine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000529	0.00384	CcSEcCtD
Bromocriptine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00052	0.00378	CcSEcCtD
Bromocriptine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000519	0.00376	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000517	0.00375	CcSEcCtD
Bromocriptine—Fatigue—Furosemide—dilated cardiomyopathy	0.000516	0.00374	CcSEcCtD
Bromocriptine—Constipation—Furosemide—dilated cardiomyopathy	0.000512	0.00371	CcSEcCtD
Bromocriptine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000494	0.00359	CcSEcCtD
Bromocriptine—Syncope—Lisinopril—dilated cardiomyopathy	0.000494	0.00358	CcSEcCtD
Bromocriptine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000493	0.00358	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00049	0.00355	CcSEcCtD
Bromocriptine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000484	0.00351	CcSEcCtD
Bromocriptine—Urticaria—Furosemide—dilated cardiomyopathy	0.000476	0.00345	CcSEcCtD
Bromocriptine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000473	0.00343	CcSEcCtD
Bromocriptine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000473	0.00343	CcSEcCtD
Bromocriptine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000467	0.00339	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000465	0.00338	CcSEcCtD
Bromocriptine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000458	0.00332	CcSEcCtD
Bromocriptine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000453	0.00329	CcSEcCtD
Bromocriptine—Oedema—Lisinopril—dilated cardiomyopathy	0.000449	0.00326	CcSEcCtD
Bromocriptine—Infection—Lisinopril—dilated cardiomyopathy	0.000446	0.00324	CcSEcCtD
Bromocriptine—Shock—Lisinopril—dilated cardiomyopathy	0.000442	0.00321	CcSEcCtD
Bromocriptine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000438	0.00318	CcSEcCtD
Bromocriptine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000436	0.00317	CcSEcCtD
Bromocriptine—Asthenia—Furosemide—dilated cardiomyopathy	0.000429	0.00312	CcSEcCtD
Bromocriptine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000428	0.00311	CcSEcCtD
Bromocriptine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00042	0.00305	CcSEcCtD
Bromocriptine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00041	0.00297	CcSEcCtD
Bromocriptine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000406	0.00295	CcSEcCtD
Bromocriptine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000403	0.00293	CcSEcCtD
Bromocriptine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.0004	0.00291	CcSEcCtD
Bromocriptine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000399	0.0029	CcSEcCtD
Bromocriptine—Dizziness—Furosemide—dilated cardiomyopathy	0.000396	0.00287	CcSEcCtD
Bromocriptine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000395	0.00287	CcSEcCtD
Bromocriptine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00039	0.00283	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000388	0.00281	CcSEcCtD
Bromocriptine—Fatigue—Lisinopril—dilated cardiomyopathy	0.000387	0.00281	CcSEcCtD
Bromocriptine—Constipation—Lisinopril—dilated cardiomyopathy	0.000384	0.00279	CcSEcCtD
Bromocriptine—Vomiting—Furosemide—dilated cardiomyopathy	0.000381	0.00276	CcSEcCtD
Bromocriptine—Rash—Furosemide—dilated cardiomyopathy	0.000377	0.00274	CcSEcCtD
Bromocriptine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000377	0.00274	CcSEcCtD
Bromocriptine—Headache—Furosemide—dilated cardiomyopathy	0.000375	0.00272	CcSEcCtD
Bromocriptine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00037	0.00269	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000367	0.00266	CcSEcCtD
Bromocriptine—ABCB1—heart—dilated cardiomyopathy	0.000361	0.00643	CbGeAlD
Bromocriptine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000357	0.00259	CcSEcCtD
Bromocriptine—Nausea—Furosemide—dilated cardiomyopathy	0.000356	0.00258	CcSEcCtD
Bromocriptine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000355	0.00258	CcSEcCtD
Bromocriptine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000355	0.00258	CcSEcCtD
Bromocriptine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000322	0.00234	CcSEcCtD
Bromocriptine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000307	0.00223	CcSEcCtD
Bromocriptine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000297	0.00216	CcSEcCtD
Bromocriptine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000286	0.00207	CcSEcCtD
Bromocriptine—Rash—Lisinopril—dilated cardiomyopathy	0.000283	0.00205	CcSEcCtD
Bromocriptine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000283	0.00205	CcSEcCtD
Bromocriptine—Headache—Lisinopril—dilated cardiomyopathy	0.000281	0.00204	CcSEcCtD
Bromocriptine—Nausea—Lisinopril—dilated cardiomyopathy	0.000267	0.00194	CcSEcCtD
Bromocriptine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.24e-05	0.000153	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.23e-05	0.000153	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.23e-05	0.000153	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.22e-05	0.000152	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.21e-05	0.000152	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.21e-05	0.000152	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.21e-05	0.000151	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.21e-05	0.000151	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.2e-05	0.000151	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.2e-05	0.000151	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.2e-05	0.000151	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.2e-05	0.000151	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.19e-05	0.00015	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.19e-05	0.00015	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AGT—dilated cardiomyopathy	2.18e-05	0.00015	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.17e-05	0.000149	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.15e-05	0.000147	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.14e-05	0.000147	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.14e-05	0.000147	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.14e-05	0.000147	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.13e-05	0.000146	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.11e-05	0.000145	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.11e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.1e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	2.1e-05	0.000144	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.1e-05	0.000144	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.08e-05	0.000142	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.08e-05	0.000142	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.07e-05	0.000142	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.07e-05	0.000142	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.07e-05	0.000142	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.06e-05	0.000141	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.06e-05	0.000141	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	2.04e-05	0.00014	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.04e-05	0.00014	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.04e-05	0.00014	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.04e-05	0.00014	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.03e-05	0.000139	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.03e-05	0.000139	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.02e-05	0.000139	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.02e-05	0.000139	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	2.01e-05	0.000138	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.01e-05	0.000138	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.01e-05	0.000138	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	2.01e-05	0.000138	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.99e-05	0.000137	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.99e-05	0.000137	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.98e-05	0.000136	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.98e-05	0.000136	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.98e-05	0.000136	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.98e-05	0.000136	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.97e-05	0.000135	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.96e-05	0.000135	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.96e-05	0.000134	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.95e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.95e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.95e-05	0.000134	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.95e-05	0.000134	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.94e-05	0.000133	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.94e-05	0.000133	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.93e-05	0.000132	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.93e-05	0.000132	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.92e-05	0.000132	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.91e-05	0.000131	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.91e-05	0.000131	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.9e-05	0.00013	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.89e-05	0.00013	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.88e-05	0.000129	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.87e-05	0.000128	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.87e-05	0.000128	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.85e-05	0.000127	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.85e-05	0.000127	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.85e-05	0.000127	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.84e-05	0.000126	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.83e-05	0.000125	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.82e-05	0.000125	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.82e-05	0.000125	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.81e-05	0.000124	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.81e-05	0.000124	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.81e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.81e-05	0.000124	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.79e-05	0.000123	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.79e-05	0.000122	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.78e-05	0.000122	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.77e-05	0.000122	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—RAC1—dilated cardiomyopathy	1.76e-05	0.000121	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.76e-05	0.000121	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	1.76e-05	0.000121	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.76e-05	0.000121	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.76e-05	0.000121	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.76e-05	0.00012	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.75e-05	0.00012	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.74e-05	0.000119	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.74e-05	0.000119	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.72e-05	0.000118	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.71e-05	0.000118	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.7e-05	0.000117	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.69e-05	0.000116	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—RAC1—dilated cardiomyopathy	1.69e-05	0.000116	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AGT—dilated cardiomyopathy	1.69e-05	0.000116	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.68e-05	0.000116	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	1.68e-05	0.000115	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.68e-05	0.000115	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.68e-05	0.000115	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.68e-05	0.000115	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.68e-05	0.000115	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.67e-05	0.000115	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.67e-05	0.000115	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	1.66e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.66e-05	0.000114	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.66e-05	0.000114	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.66e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	1.65e-05	0.000113	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.64e-05	0.000112	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.63e-05	0.000112	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.63e-05	0.000112	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.61e-05	0.000111	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AGT—dilated cardiomyopathy	1.61e-05	0.00011	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.61e-05	0.00011	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	1.6e-05	0.00011	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.6e-05	0.00011	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.56e-05	0.000107	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.54e-05	0.000105	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.53e-05	0.000105	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.53e-05	0.000105	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.52e-05	0.000104	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.52e-05	0.000104	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—RAF1—dilated cardiomyopathy	1.52e-05	0.000104	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.51e-05	0.000104	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.5e-05	0.000103	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	1.5e-05	0.000103	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.5e-05	0.000103	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.5e-05	0.000103	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.48e-05	0.000101	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.47e-05	0.0001	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.46e-05	0.0001	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.45e-05	9.97e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.45e-05	9.96e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	1.45e-05	9.95e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.45e-05	9.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	1.44e-05	9.9e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.44e-05	9.86e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	1.43e-05	9.82e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AGT—dilated cardiomyopathy	1.43e-05	9.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.42e-05	9.76e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.42e-05	9.72e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.4e-05	9.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.4e-05	9.57e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.39e-05	9.55e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.38e-05	9.44e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.37e-05	9.36e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.36e-05	9.31e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.36e-05	9.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.35e-05	9.27e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.35e-05	9.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	1.34e-05	9.17e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.32e-05	9.06e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.32e-05	9.05e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.31e-05	8.95e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	1.3e-05	8.94e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	1.3e-05	8.93e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.3e-05	8.91e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.3e-05	8.9e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	1.29e-05	8.86e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.29e-05	8.82e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.27e-05	8.7e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.27e-05	8.68e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	1.26e-05	8.66e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.25e-05	8.56e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.25e-05	8.55e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	1.24e-05	8.53e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.24e-05	8.51e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.24e-05	8.5e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.24e-05	8.5e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.22e-05	8.38e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	1.21e-05	8.28e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.2e-05	8.24e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	1.19e-05	8.15e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	8.04e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—RAF1—dilated cardiomyopathy	1.17e-05	8.02e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.17e-05	8.01e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	1.17e-05	8.01e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	1.16e-05	7.96e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.15e-05	7.91e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.15e-05	7.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.15e-05	7.9e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.15e-05	7.86e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.14e-05	7.79e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.14e-05	7.79e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.13e-05	7.73e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—RAF1—dilated cardiomyopathy	1.12e-05	7.67e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.1e-05	7.57e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	1.1e-05	7.51e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	1.08e-05	7.39e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	1.07e-05	7.32e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.06e-05	7.24e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.05e-05	7.2e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.04e-05	7.14e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—EGFR—dilated cardiomyopathy	1.04e-05	7.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.03e-05	7.04e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.01e-05	6.9e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.01e-05	6.89e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	1e-05	6.86e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	9.93e-06	6.81e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—RAF1—dilated cardiomyopathy	9.93e-06	6.81e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	9.81e-06	6.72e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.73e-06	6.67e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.57e-06	6.56e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	9.25e-06	6.34e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.05e-06	6.21e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	9.01e-06	6.18e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	8.97e-06	6.15e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.82e-06	6.05e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.68e-06	5.95e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	8.66e-06	5.94e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	8.61e-06	5.91e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.5e-06	5.83e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	8.38e-06	5.74e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	8.25e-06	5.65e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	8.11e-06	5.56e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EGFR—dilated cardiomyopathy	8.02e-06	5.5e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	8.01e-06	5.49e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	7.96e-06	5.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.9e-06	5.42e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.79e-06	5.34e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EGFR—dilated cardiomyopathy	7.67e-06	5.26e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	7.6e-06	5.21e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.48e-06	5.13e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	7.38e-06	5.06e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	7.32e-06	5.02e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.32e-06	5.02e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	7.19e-06	4.93e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.9e-06	4.73e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	6.81e-06	4.67e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—dilated cardiomyopathy	6.81e-06	4.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.8e-06	4.67e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	6.47e-06	4.44e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.21e-06	4.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.15e-06	4.22e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.94e-06	4.07e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	5.91e-06	4.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	5.75e-06	3.94e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.7e-06	3.91e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	5.65e-06	3.88e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.55e-06	3.8e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	5.21e-06	3.57e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.13e-06	3.52e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	5.02e-06	3.44e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5e-06	3.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.67e-06	3.2e-05	CbGpPWpGaD
